Encompass Health Corporation

EHC • Medical - Care Facilities

$121.79

▼ -0.80 (-0.65%)

Precio actual

ResultadosÚltimo reporte: 30 jun 2026

PERFIL FAVORABLEAtractivaConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Alta calidad del negocio, con crecimiento y flujo de caja que respaldan el caso. La valoración todavía importa, pero el historial de ratios es favorable.

Capitalización

$12.18B

Crecimiento

16.0%

Flujo de caja

5/5

Tendencia

Stable

Evidencia

Márgenes estables o en mejora · 9.5%Crecimiento positivo de ingresos · 9.9%Flujo de caja libre positivo · 4.37Flujo de caja libre consistente · 5/5Múltiplo de ganancias razonable · 18.84

Datos financieros hasta: 30 jun 2026, 12:00 a.m. UTCÚltima actualización de earnings: 30 jun 2026, 12:00 a.m. UTCÚltima actualización del perfil: 7 ago 2026, 1:55 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$121.79

Change-0.65%

Shares Out100.00M

Market Cap$12.18B

Enterprise Value$14.71B

52W Range92.77 - 127.99

Beta0.60

P/E19.61

P/S1.96

P/B4.69

P/FCF21.59

EV/Sales2.37

Price$121.79

Change-0.65%

Shares Out100.00M

Market Cap$12.18B

Enterprise Value$14.71B

52W Range92.77 - 127.99

Beta0.60

P/E19.61

P/S1.96

P/B4.69

P/FCF21.59

EV/Sales2.37

EV/EBITDA9.93

EV/FCF26.07

Earnings Yield5.10%

FCF Yield4.63%

Dividend Yield0.78%

Gross Margin95.71%

Oper. Margin17.74%

Profit Margin9.54%

Debt/Eq1.11

Current Ratio1.08

Quick Ratio1.08

Revenue 5Y15.96%

Target$150.25

Target Upside23.37%

Target Median$151.00

Target Range144.00 - 155.00

Volume39.91K

Avg Volume1.01M

EPS Surprise0.09

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

70/100

Fortaleza financiera

Deuda, caja, estabilidad

66/100

Potencial de crecimiento

Ingresos y expansión

95/100

Atractivo del precio

Barata o cara hoy

74/100

Por qué este puntaje▼

Márgenes estables o en mejora · 9.5%Crecimiento positivo de ingresos · 9.9%Flujo de caja libre positivo · 4.37Flujo de caja libre consistente · 5/5Múltiplo de ganancias razonable · 18.84

Analyst view

Analyst sentiment and price target

EHC

Analyst sentiment

Based on 27 analyst votes · 2026-09-05

89/100

Bullish

Hold

Bearish

Precio objetivo

2026-08-07

Bajo

$144.00

Promedio

$148.00

Mediana

$148.00

Alto

$152.00

Resumen de la compañía

IPO: 9/24/1986

Industria: Medical - Care Facilities

P/B i: 4.69

Deuda / Patrimonio i: 1.11

Margen operativo: 17.74%

Margen neto: 9.54%

ROE i: -

ROIC: -

Salud financiera

Puntaje13 / 20

Deuda / Patrimonio: 1.11

Ratio corriente: 1.08

Ratio rápido: 1.08

Estado: Good

Transacciones internas

Actividad reciente de ejecutivos e insiders

Christie Edward M III

Transacción: 07/16/2026

COMPRA

Cambio

+248

Precio

$112.43

Presentación

07/16/2026

Tipo

COMPRA

Reidy Christopher R

Transacción: 07/16/2026

COMPRA

Cambio

+319

Precio

$112.40

Presentación

07/16/2026

Tipo

COMPRA

CARMICHAEL GREG D

Transacción: 07/15/2026

COMPRA

Cambio

+29

Precio

Not reported

Presentación

07/16/2026

Tipo

COMPRA

Insider	Tipo	Cambio	Precio	Transacción	Presentación
Christie Edward M III	COMPRA	+248	$112.43	07/16/2026	07/16/2026
Reidy Christopher R	COMPRA	+319	$112.40	07/16/2026	07/16/2026
CARMICHAEL GREG D	COMPRA	+29	Not reported	07/15/2026	07/16/2026
Hayes Cain A	COMPRA	+4	Not reported	07/15/2026	07/16/2026
HERMAN JOAN E	COMPRA	+85	Not reported	07/15/2026	07/16/2026
KATZ LESLYE G	COMPRA	+85	Not reported	07/15/2026	07/16/2026
O'Connor Kevin J.	COMPRA	+19	Not reported	07/15/2026	07/16/2026
SCHLICHTING NANCY M	COMPRA	+40	Not reported	07/15/2026	07/16/2026
Williams Terrance	COMPRA	+29	Not reported	07/15/2026	07/16/2026
Christie Edward M III	COMPRA	+11	Not reported	07/15/2026	07/16/2026
Reidy Christopher R	COMPRA	+21	Not reported	07/15/2026	07/16/2026
COLTHARP DOUGLAS E	VENTA	-27,694	$32.94	05/15/2026	05/18/2026
COLTHARP DOUGLAS E	VENTA	-1	$107.28	05/15/2026	05/18/2026
Tuer Patrick William	VENTA	-682	$104.56	05/11/2026	05/12/2026
SCHLICHTING NANCY M	COMPRA	+1,634	Not reported	05/07/2026	05/11/2026
HERMAN JOAN E	COMPRA	+1,634	Not reported	05/07/2026	05/11/2026
KATZ LESLYE G	COMPRA	+1,634	Not reported	05/07/2026	05/11/2026
Williams Terrance	COMPRA	+1,634	Not reported	05/07/2026	05/11/2026
CARMICHAEL GREG D	COMPRA	+1,634	Not reported	05/07/2026	05/11/2026
Hayes Cain A	COMPRA	+1,634	Not reported	05/07/2026	05/11/2026

Sobre la compañía

Encompass Health Corporation

Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.

Fuente - Link

Competidores

ALGN CHE DVA ELAN ENSG FMS ICLR RDY SOLV UHS

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

Why Is Encompass Health (EHC) Down 1.8% Since Last Earnings Report?

Encompass Health (EHC) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research

76,400 Shares in Encompass Health Corporation $EHC Purchased by Canada Pension Plan Investment Board

Canada Pension Plan Investment Board acquired a new position in Encompass Health Corporation (NYSE: EHC) in the quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 76,400 shares of the company's stock, valued at approximately $7,723,000. Canada Pension Plan Investment Board owned

Defense World

Deutsche Bank AG Invests $1.28 Million in Encompass Health Corporation $EHC

Deutsche Bank AG purchased a new stake in Encompass Health Corporation (NYSE: EHC) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 12,716 shares of the company's stock, valued at approximately $1,285,000. Several other hedge funds and other institutional investors have

Defense World

Encompass Health Is Healthy Enough To Justify A Bullish View

Encompass Health Corporation is the largest U.S. inpatient rehabilitation hospital operator, showing robust top- and bottom-line growth with industry-leading balance sheet strength. EHC is executing a disciplined expansion strategy, targeting 6–10 new hospitals and 80–120 bed additions annually, supported by favorable US demographic trends. Despite trading at a premium to peers, EHC's valuation remains attractive given its growth, profitability, and declining net leverage ratio.

Seeking Alpha

Ancora Advisors LLC Buys New Stake in Encompass Health Corporation $EHC

Ancora Advisors LLC purchased a new stake in Encompass Health Corporation (NYSE: EHC) during the second quarter, according to its most recent filing with the SEC. The fund purchased 105,258 shares of the company's stock, valued at approximately $10,639,000. Ancora Advisors LLC owned about 0.11% of Encompass Health as of its most recent

Defense World

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-04-30	1.51	1.6	0.09
2026-02-05	1.29	1.46	0.17
2025-10-29	1.19	1.23	0.04
2025-08-04	1.23	1.4	0.17
2025-04-24	1.19	1.37	0.18
2025-02-06	1.05	1.17	0.12
2024-10-28	0.94	1.03	0.09
2024-08-05	1.01	1.11	0.1
2024-04-24	0.94	1.12	0.18
2024-02-07	0.82	0.95	0.13
2023-10-26	0.77	0.86	0.09
2023-08-01	0.75	0.95	0.2